PRL and paracoccidioidomycosis: The use of bromocriptine is based on the observation of an enhanced oxidative stress-mediated cleavage of the nursing hormone prolactin into the antiangiogenic and proapoptotic 16-kDa fragment (see above), which could take part in PCM development.